Concepedia

mFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO-KRK0109)

U.M. Martens, R. Knorrenschield, J. Greeve, A. Florschuetz, A. Tannapfel, S. Wessendorf, Thomas Seufferlein, S. Kanzler, V. Heinemann, S. Held,

Annals of Oncology · 2017 · 24 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyGastrointestinal OncologyImmunotherapyMetastasisCancer ImmunotherapyColorectal CancerCombination ChemotherapyCombination ImmunotherapyMetastatic Disease TreatmentMetastatic Gastrointestinal CancerMetastasis-directed Therapy